The STAT5 whole “kinome” that links ROS with STAT5 phosphorylation, as well as downstream ROS and calcium-dependent gene expression, may be exploited to identify potential therapeutic targets of value for high risk AML. This evidence concerns the gene STAT5A and acute myeloid leukemia.